Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -134.94x is 637% below its 5-year average of -18.31x, around the middle of its 5-year range (-1995.49x–789.65x).
78.77% above its 12-month average of -635.62x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -30.27x.
INTEREST COVERAGE RATIO
-134.94x
INTEREST COVERAGE RATIO AVG TTM
-635.62x
INTEREST COVERAGE RATIO AVG 3Y
-18.23x
INTEREST COVERAGE RATIO AVG 5Y
-18.31x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+78.77%
CURRENT VS 3Y AVG
-640.16%
CURRENT VS 5Y AVG
-637.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.24x
median of 361 covered companies
CURRENT VS SECTOR MEDIAN
-3082.55%
vs the sector median at left
Jupiter Neurosciences, Inc.
Market Cap
$1.16M
Interest Coverage Ratio
-134.94x
TTM Avg
-635.62x
3Y Avg
-18.23x
5Y Avg
-18.31x
Market Cap
$1.19M
Interest Coverage Ratio
-4.20x
TTM Avg
1.01x
3Y Avg
1.00x
5Y Avg
1.00x
Market Cap
$1.11M
Interest Coverage Ratio
-7.46x
TTM Avg
10.39x
3Y Avg
21.90x
5Y Avg
21.90x
Market Cap
$1.10M
Interest Coverage Ratio
-290.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02M
Interest Coverage Ratio
-2.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.38M
Interest Coverage Ratio
-58.78x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$898130.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$893920.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jupiter Neurosciences, Inc. (JUNS) | $1.16M | -134.94x | -635.62x | -18.23x | -18.31x |
| IM Cannabis Corp. (IMCC)vs › | $1.19M | -4.20x | 1.01x | 1.00x | 1.00x |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.11M | -7.46x | 10.39x | 21.90x | 21.90x |
| Clearmind Medicine Inc. (CMND)vs › | $1.10M | -290.08x | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -2.27x | N/A | N/A | N/A |
| Genprex, Inc. (GNPX)vs › | $1.31M | -20.97x | N/A | N/A | N/A |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.38M | -58.78x | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $898130.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | 354.05x | 372.60x | 299.52x |
| Decoy Therapeutics Inc. (DCOY)vs › | $880673.00 | N/A | N/A | N/A | N/A |
Interest Coverage
-134.9x
Debt/Equity
N/A
Current Ratio
0.66
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -30.27x |
| 2026-03-31 | -16.55x |
| 2025-12-31 | 789.65x |
| 2025-09-30 | -1925.44x |
| 2025-06-30 | -1995.49x |
| 2025-03-31 | -1251.43x |
| 2024-12-31 | -47.74x |
| 2024-09-30 | -4.60x |
| 2024-06-30 | -9.90x |
| 2024-03-31 | -8.68x |
| 2023-12-31 | -9.17x |
| 2023-09-30 | -17.89x |
| 2023-06-30 | -19.28x |
| 2023-03-31 | -21.79x |
| 2022-06-30 | -2.30x |
| 2022-03-31 | -9.52x |
| 2021-12-31 | -22.46x |
| 2021-09-30 | -36.13x |
| 2021-06-30 | -149.44x |
| 2021-03-31 | -116.22x |
| 2020-12-31 | -69.72x |
| 2020-09-30 | -113.33x |
